Artificial Intelligence | Machine Learning | Machine Perception Unlearn.ai | Accelerating Clinical Trials with AI


Biotechnology, Computer Software, Pharmaceuticals, Clinical Trials, Life Sciences San Francisco, CA, United States

Unlearn.ai

Artificial Intelligence | Machine Learning | Machine Perception


Unlearn.ai | Accelerating Clinical Trials with AI

Unlearn.ai

Biotechnology, Computer Software, Pharmaceuticals, Clinical Trials, Life Sciences


San Francisco, CA, United States

Unlearn.AI is a developer of a platform designed to make computational clinical trials. The company's platform accelerates clinical trials by supplementing control groups with synthetic patient data generated using AI, which helps in reducing the time to develop new medicines, enabling healthcare companies to sooner provide patients in need with life-saving therapies. Creating AI to simulate biology and improve the lives of patients. Unlearn was founded by scientists, who wanted to find a new, evidence-based approach. We operate based on proprietary approaches to machine learning principles and regulatory guidances.

 

B2G, B2B

26 to 50

Series A

$12 M

Scaling Up

2017

 
 

Pharmaceuticals
Managed Health Care
Health Care Facilities & Hospitals
Computer Software
Biotechnology

N/A

Increase Efficiency

 
 

Analytics
IT and Security
Service

Yes

Active

 
 

   Machine Learning
   Machine Perception
   Natural Language Processing
   Knowledge Representation and Reasoning


N/A


Image

Image

Video

Video

Audio

Audio

Text

Text

Time Series

Time Series

 

   Software


N/A


N/A

 
 

View All

View All AI/ML Jobs

Senior Data Engineer

San Francisco, California

Data Scientist

San Francisco, California

Technical Product Manager

San Francisco, California

Senior DevOps Engineer

San Francisco, California

Recruiter

San Francisco, California

 
 

3

1

$3 M

Company was founded 2017 and it took almost 3 years (Nov 2020) to raise first external round

 
 

Date

Round

$ Raised

Investors

11/05/2020

Series A

$3 M

Eisai, EPIC Ventures, Alumni Ventures Group

Date : 11/05/2020

Round: Series A

$ Raised: $3 M

Investors: Eisai, EPIC Ventures, Alumni Ventures Group

 
 
Charles Fisher


Charles Fisher
Founder and CEO

Aaron Smith


Aaron Smith
Founder

Julia Coelho


Julia Coelho
Chief Commercial Officer

Graham Siegel


Graham Siegel
COO

Jonathan Walsh


Jonathan Walsh
Founder, Head of Data Science